SPDR S&P Pharmaceuticals ETF Forecast
Red day on Tuesday for SPDR S&P Pharmaceuticals
(Updated on May 21, 2024)
The SPDR S&P Pharmaceuticals ETF price fell by -0.339% on the last day (Tuesday, 21st May 2024) from $41.28 to $41.14. During the last trading day the ETF fluctuated 0.560% from a day low at $41.10 to a day high of $41.33. The price has risen in 6 of the last 10 days and is up by 1.03% over the past 2 weeks. Volume fell on the last day along with the ETF, which is actually a good sign as volume should follow the ETF. On the last day, the trading volume fell by -9 thousand shares and in total, 8 thousand shares were bought and sold for approximately $324.60 thousand.
The ETF lies the upper part of a falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $41.20 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the ETF is expected to fall -10.26% during the next 3 months and, with a 90% probability hold a price between $33.85 and $36.97 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
XPH Signals & Forecast
The SPDR S&P Pharmaceuticals ETF holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the ETF giving a positive forecast for the stock. On further gains, the ETF will meet resistance from the short-term Moving Average at approximately $41.20. On a fall, the ETF will find some support from the long-term average at approximately $40.57. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 5.24%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this ETF may have low liquidity in periods, which increases the general risk. The ETF had a Golden Star Signal on Monday, July 17, 2023 in the long-term chart.
Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.
Golden Star 12 Months
The ETF had a Golden Star Signal on Monday, July 17, 2023 in the long-term chart.Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.
Support, Risk & Stop-loss for SPDR S&P Pharmaceuticals ETF
SPDR S&P Pharmaceuticals finds support from accumulated volume at $41.13 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the ETF tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the ETF During the last day, the ETF moved $0.230 between high and low, or 0.560%. For the last week the ETF has had daily average volatility of 0.626%
Our recommended stop-loss: $39.62 (-3.70%) (This ETF has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 59 days ago.)
Trading Expectations (XPH) For The Upcoming Trading Day Of Wednesday 22nd
For the upcoming trading day on Wednesday, 22nd we expect SPDR S&P Pharmaceuticals ETF to open at $41.19, and during the day (based on 14 day Average True Range), to move between $40.70 and $41.58, which gives a possible trading interval of +/-$0.445 (+/-1.08%) up or down from last closing price. If SPDR S&P Pharmaceuticals ETF takes out the full calculated possible swing range there will be an estimated 2.16% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $41.13 (0.02%) than the resistance at $41.40 (0.63%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is SPDR S&P Pharmaceuticals ETF ETF A Buy?
Several short-term signals are positive, despite the ETF being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for ETF to perform well in the short-term.
Current score: 2.037 Buy Candidate Unchanged
Predicted Opening Price for SPDR S&P Pharmaceuticals ETF of Wednesday, May 22, 2024
Fair opening price May 22, 2024 | Current price |
---|---|
$41.19 ( 0.122%) | $41.14 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for XPH
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 41.42 | 0.681 % | |
R2 | 41.33 | 0.467 % | ||
R1 | 41.28 | 0.335 % | ||
Current price: | 41.14 | |||
Support | S1 | 41.10 | -0.0920 % | |
S2 | 41.05 | -0.224 % | ||
S3 | 40.96 | -0.438 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 43.13 | 4.84 % | |
R2 | 42.31 | 2.84 % | ||
R1 | 41.40 | 0.632 % | ||
Current price | 41.14 | |||
Support | S1 | 41.13 | -0.0243% | |
S2 | 40.15 | -2.41% | ||
S3 | 39.09 | -4.98% |
XPH Dividend Payout History
# | Ex-Date | Pay Date | Amount | Yield | |
---|---|---|---|---|---|
1 | Mar 18, 2024 | Mar 18, 2024 | Mar 21, 2024 | $0.173 | 0.402% |
2 | Dec 18, 2023 | Dec 18, 2023 | Dec 18, 2023 | $0.174 | 0.438% |
3 | Jan 26, 2023 | Sep 18, 2023 | Sep 21, 2023 | $0.120 | 0.295% |
4 | Jan 26, 2023 | Jun 20, 2023 | Jun 23, 2023 | $0.124 | 0.300% |
5 | Jan 26, 2023 | Mar 20, 2023 | Mar 23, 2023 | $0.115 | 0.289% |
FAQ
Click here for our free guide on how to buy SPDR S&P Pharmaceuticals ETF ETF.